CC Ipol Polio 4 Vacc 0.5ml (Poliomyelitis Vaccine Vaccine)

Ipol Polio 4 Vacc 0.5ml (Poliomyelitis Vaccine)

Product Description:
Ipol Polio 4 Vacc 0.5ml is an inactivated poliovirus vaccine designed to induce immunity against poliomyelitis (polio). This vaccine is formulated for intramuscular or subcutaneous administration and contains strains of all three serotypes of poliovirus: type 1 (Mahoney), type 2 (MEF-1), and type 3 (Saukett).

Technician Specifications:
- Composition: Each 0.5ml dose contains inactivated poliovirus types 1, 2, and 3.
- Preservative: 2-phenoxyethanol and formaldehyde are used as preservatives.
- Adjuvant: Contains aluminum salts to enhance the immune response.
- Storage: Store refrigerated between 2°C and 8°C. Do not freeze.
- Shelf Life: Check the expiration date on the package for shelf life information.
- Administration: Suitable for intramuscular or subcutaneous injection.
- Packaging: Available in single-dose vials or pre-filled syringes.

Common Applications/User Groups:
- Primary vaccination: Administered to infants and children as part of the routine immunization schedule.
- Booster doses: Given to maintain immunity in children and adults at risk of poliovirus exposure.
- Travel vaccination: Recommended for travelers to areas where polio is endemic or where outbreaks are occurring.
- Healthcare workers: Essential for healthcare professionals working in areas with increased risk of poliovirus transmission.

Supplier Overview - Sanofi Aventis:
Sanofi Aventis, the supplier of Ipol Polio 4 Vacc 0.5ml, is a global leader in healthcare and pharmaceuticals. With a strong commitment to research and development, Sanofi Aventis has a rich history of innovation in vaccine technology. Their expertise in the field of immunization is well-established, making them a trusted authority in the production and distribution of vaccines. The company's dedication to global health and safety standards ensures that their products, including the Ipol Polio Vaccine, meet the highest quality and efficacy requirements. Sanofi Aventis's contribution to the eradication of polio underscores their position as a key player in the fight against infectious diseases worldwide.